Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Phase 3UnknownNCT01281072

Hadassah Medical Organization

Overview

Open label study to evaluate long term treatment effect of diapep277.

Study Type

INTERVENTIONAL

Allocation

Sex: ALLMin age: 20 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1\. patient that completed 901 and 910 study. Exclusion Criteria: 1\. cpeptide\<0.2

c peptide reserve

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.